Finding the best vehicle in which to publish your research findings is a perennial challenge. Choosing the wrong journal can result in your publication being delayed with you having to commit considerable resources to handling unnecessary journal rejections and preparing alternative journal submissions. One of the most common reasons for manuscript rejection is poorly considered journal selection. An informed process that targets optimal journal identification will save you time, money and heartache. Our handy guide Ready!, Aim!, Fire! released this week is already one of our most downloaded Insider’s Insights [1].
Choosing which journal to publish in has become more and more complex following the many changes to the publishing landscape. Open access, online only and pay-to-view choices have been added to the more traditional considerations: impact factor, publication lead-time and your target journal’s ambition to be identified as an elite publication. The proliferation of new journals and novel areas of specialisation coupled with the emergence of interdisciplinary topics have only served to further confound the selection process. Key takeaways include:
If you are still struggling to decide which journal to select we would normally ask ourselves whether the findings of the work shifts any paradigms in the field. If yes, we advise the author to aim for the highest impact, broader scope journal in the list. If the findings are solid and the study complete, but unlikely to be paradigm-changing we would advise an author to go for the specialty journal in the field that is read by most investigators in that area. Our work suggests that little attention has been focused in the scientific literature on the mechanisms that authors use to select a journal for their work. Nevertheless, scientists for the most part seem to have a good sense of where their papers are most likely to be accepted.
References
The largest pharmaceutical companies not surprisingly rely on the largest contract research organizations
Scientific knowledge should be accessible to all and if you are those communicating science
Searching the literature can take various forms, ranging from a quick scan of recent publications
Every year, a huge amount of scientific data is released. It's out there, but how do you find it?
Experience at Niche has taught us that clinical study protocols are born in the white-hot fire
Advisory board meetings are often used to address perceived knowledge gaps and build consensus.
I am continually reminded that I must work toward better relationships with my sons than the one I had with my dad.
We recently encouraged writers (of all kinds) in our recent Insider’s Insight to experiment with large language.
Investigator sites are very important to clinical studies because they make sure that new drugs are safe and work well.
Since 2013 we have been sharing our understanding on key issues with friends and clients via our Insider’s Insights.
Did you miss our Insider's Insight into understanding the complex world of bibliometrics [1]?
Have you seen our latest Insider's Insight on Case Reports? Once a staple of medical journals,
Our team are exploring different and novel ways for young people to enter the pharmaceutical industry.
Concerns about readiness of the European Medicines Agency’s (EMA) Clinical Trials Information System persist as the.
The clinical stage biotechnology company developing breakthrough therapies for patients suffering with cancer,
Finding the best vehicle in which to publish your research findings is a perennial challenge.
In the past, Halloween has meant the end of the crop and the start of the dark, cold winter.
Investigator-Initiated Clinical Trials (IITs) are clinical studies led by academic researchers or clinicians
I have never been great at conferences. People don’t believe me but I am painfully shy and far too worried about what.
Welcome to the seventh issue of the Refractory Asthma Stratification Programme (RASP-UK) newsletter
The proceedings of the Association for Human Pharmacology in the Pharmaceutical Industry (AHPPI)
We all need heroes - people who can champion our cause - helping the world to understand our rationale
Get our latest news and publications
Sign up to our news letterSocial
Contact us
Address
Niche Science & Technology
Unit 26 Falstaff House
Bardolph Road
Richmond TW9 2LH
United Kingdom
